395 related articles for article (PubMed ID: 15123278)
21. Applications of emerging technologies in toxicology and safety assessment.
Reynolds VL
Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
[TBL] [Abstract][Full Text] [Related]
22. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
23. Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.
Leighton JK
Int J Toxicol; 2005; 24(3):153-5. PubMed ID: 16040567
[TBL] [Abstract][Full Text] [Related]
24. Application of microarray-based analysis of gene expression in the field of toxicogenomics.
Mei N; Fuscoe JC; Lobenhofer EK; Guo L
Methods Mol Biol; 2010; 597():227-41. PubMed ID: 20013237
[TBL] [Abstract][Full Text] [Related]
25. Application of toxicogenomics to drug development.
Lakkis MM; DeCristofaro MF; Ahr HJ; Mansfield TA
Expert Rev Mol Diagn; 2002 Jul; 2(4):337-45. PubMed ID: 12138498
[TBL] [Abstract][Full Text] [Related]
26. Predictive toxicogenomics in preclinical discovery.
Barros SA; Martin RB
Methods Mol Biol; 2008; 460():89-112. PubMed ID: 18449484
[TBL] [Abstract][Full Text] [Related]
27. Toxicogenomics in risk assessment: applications and needs.
Boverhof DR; Zacharewski TR
Toxicol Sci; 2006 Feb; 89(2):352-60. PubMed ID: 16221963
[TBL] [Abstract][Full Text] [Related]
28. Application of genomics in preclinical drug safety evaluation.
Lord PG; Nie A; McMillian M
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):537-46. PubMed ID: 16700814
[TBL] [Abstract][Full Text] [Related]
29. Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
Currie RA; Orphanides G; Moggs JG
Reprod Toxicol; 2005; 20(3):433-40. PubMed ID: 15964738
[TBL] [Abstract][Full Text] [Related]
30. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals.
Li HH; Aubrecht J; Fornace AJ
Mutat Res; 2007 Oct; 623(1-2):98-108. PubMed ID: 17548094
[TBL] [Abstract][Full Text] [Related]
31. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
van Dartel DA; Piersma AH
Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
[TBL] [Abstract][Full Text] [Related]
32. A toxicogenomics-based parallelogram approach to evaluate the relevance of coumarin-induced responses in primary human hepatocytes in vitro for humans in vivo.
Kienhuis AS; van de Poll MC; Dejong CH; Gottschalk R; van Herwijnen M; Boorsma A; Kleinjans JC; Stierum RH; van Delft JH
Toxicol In Vitro; 2009 Sep; 23(6):1163-9. PubMed ID: 19527782
[TBL] [Abstract][Full Text] [Related]
33. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
Ganter B; Snyder RD; Halbert DN; Lee MD
Pharmacogenomics; 2006 Oct; 7(7):1025-44. PubMed ID: 17054413
[TBL] [Abstract][Full Text] [Related]
34. Toxicogenomics and systems toxicology: aims and prospects.
Waters MD; Fostel JM
Nat Rev Genet; 2004 Dec; 5(12):936-48. PubMed ID: 15573125
[TBL] [Abstract][Full Text] [Related]
35. A review of toxicogenomic approaches in developmental toxicology.
Robinson JF; Pennings JL; Piersma AH
Methods Mol Biol; 2012; 889():347-71. PubMed ID: 22669676
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling approaches for identifying novel biomarkers.
Bailey WJ; Ulrich R
Expert Opin Drug Saf; 2004 Mar; 3(2):137-51. PubMed ID: 15006720
[TBL] [Abstract][Full Text] [Related]
37. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
38. Novel biomarkers of acute kidney toxicity.
Goodsaid FM; Blank M; Dieterle F; Harlow P; Hausner E; Sistare F; Thompson A; Vonderscher J
Clin Pharmacol Ther; 2009 Nov; 86(5):490-6. PubMed ID: 19710639
[TBL] [Abstract][Full Text] [Related]
39. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
40. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
